Full Notification

Sanofi US is voluntarily recalling all of its epinephrine injections (Auvi-Q) on the market because patients taking it for life-threatening anaphylaxis may receive an inaccurate and inadequate dose, the US Food and Drug Administration (FDA) announced October 29, 2015.

To report any problems with Auvi-Q epinephrine injection, contact MedWatch, the FDA's safety information and adverse event reporting program, by telephone at 1-800-FDA-1088; by fax at 1-800-FDA-0178; online at https://www.accessdata.fda.gov/scripts/medwatch/medwatch-online.htm

Click on link for more information!

http://www.medscape.com/viewarticle/853445nlid=90083_3663&src=wnl_edit_newsal&uac=167024MZ&impID=871601&faf=1